Antibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN965973 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Solute Carrier Family 6 (Neurotransmitter Transporter, Dopamine), Member 3 (SLC6A3) (N-Term) antibody
- Antibody type
- Polyclonal
- Antigen
- Polyclonal antibody produced in rabbits immunizing with a synthetic peptide corresponding to N-terminal residues of human DAT(Sodium-dependent dopamine transporter)
- Reactivity
- Human
- Host
- Rabbit
- Vial size
- 0.1mg
- Storage
- Store at -20°C.
Submitted references Evidence for linkage disequilibrium between the dopamine transporter and bipolar disorder.
Functional interaction between monoamine plasma membrane transporters and the synaptic PDZ domain-containing protein PICK1.
Human dopamine transporter gene: coding region conservation among normal, Tourette's disorder, alcohol dependence and attention-deficit hyperactivity disorder populations.
Human and mouse dopamine transporter genes: conservation of 5'-flanking sequence elements and gene structures.
Pharmacological heterogeneity of the cloned and native human dopamine transporter: disassociation of [3H]WIN 35,428 and [3H]GBR 12,935 binding.
A human dopamine transporter cDNA predicts reduced glycosylation, displays a novel repetitive element and provides racially-dimorphic TaqI RFLPs.
Greenwood TA, Alexander M, Keck PE, McElroy S, Sadovnick AD, Remick RA, Kelsoe JR
American journal of medical genetics 2001 Mar 8;105(2):145-51
American journal of medical genetics 2001 Mar 8;105(2):145-51
Functional interaction between monoamine plasma membrane transporters and the synaptic PDZ domain-containing protein PICK1.
Torres GE, Yao WD, Mohn AR, Quan H, Kim KM, Levey AI, Staudinger J, Caron MG
Neuron 2001 Apr;30(1):121-34
Neuron 2001 Apr;30(1):121-34
Human dopamine transporter gene: coding region conservation among normal, Tourette's disorder, alcohol dependence and attention-deficit hyperactivity disorder populations.
Vandenbergh DJ, Thompson MD, Cook EH, Bendahhou E, Nguyen T, Krasowski MD, Zarrabian D, Comings D, Sellers EM, Tyndale RF, George SR, O'Dowd BF, Uhl GR
Molecular psychiatry 2000 May;5(3):283-92
Molecular psychiatry 2000 May;5(3):283-92
Human and mouse dopamine transporter genes: conservation of 5'-flanking sequence elements and gene structures.
Donovan DM, Vandenbergh DJ, Perry MP, Bird GS, Ingersoll R, Nanthakumar E, Uhl GR
Brain research. Molecular brain research 1995 Jun;30(2):327-35
Brain research. Molecular brain research 1995 Jun;30(2):327-35
Pharmacological heterogeneity of the cloned and native human dopamine transporter: disassociation of [3H]WIN 35,428 and [3H]GBR 12,935 binding.
Pristupa ZB, Wilson JM, Hoffman BJ, Kish SJ, Niznik HB
Molecular pharmacology 1994 Jan;45(1):125-35
Molecular pharmacology 1994 Jan;45(1):125-35
A human dopamine transporter cDNA predicts reduced glycosylation, displays a novel repetitive element and provides racially-dimorphic TaqI RFLPs.
Vandenbergh DJ, Persico AM, Uhl GR
Brain research. Molecular brain research 1992 Sep;15(1-2):161-6
Brain research. Molecular brain research 1992 Sep;15(1-2):161-6
No comments: Submit comment
No validations: Submit validation data